Results 21 to 30 of about 9,727 (224)

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease [PDF]

open access: goldClinical Medicine Insights: Oncology, 2015
Introduction Gemcitabine is a chemotherapeutic agent frequently used by for the treatment of several malignancies both in the adjuvant and metastatic setting.
Célia Turco   +10 more
doaj   +3 more sources

Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension [PDF]

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2019
Pulmonary veno-occlusive disease (PVOD) is a rare entity that is usually mistaken with pulmonary arterial hypertension (PAH) but is considered class I′ of PAH. It is important to subclassify PVOD and distinguish it from PAH as treatment with vasodilators
Said Hajouli MD   +2 more
doaj   +2 more sources

Late Onset Pulmonary Arterial Hypertension Associated With Features of Pulmonary Veno‐Occlusive Disease and Rare Heterozygous Variants of KDR and EIF2AK4 [PDF]

open access: yesPulmonary Circulation
The natural history of late‐onset pulmonary arterial hypertension (PAH) with features of venous/capillary involvement and the associations with rare variants in PAH genes are not well known.
Vasile Foris   +11 more
doaj   +2 more sources

Mechanisms underlying age-associated exacerbation of pulmonary veno-occlusive disease [PDF]

open access: yesJCI Insight
Pulmonary veno-occlusive disease (PVOD) is a rare but severe form of pulmonary hypertension characterized by the obstruction of pulmonary arteries and veins, causing increased pulmonary artery pressure and leading to right ventricular (RV) heart failure.
Amit Prabhakar   +8 more
doaj   +2 more sources

Comprehensive three‐dimensional morphology of neoangiogenesis in pulmonary veno‐occlusive disease and pulmonary capillary hemangiomatosis

open access: goldThe Journal of Pathology: Clinical Research, 2019
Pulmonary veno‐occlusive disease (PVOD) is a rare lung disease characterized by fibrotic narrowing of pulmonary veins leading to pulmonary hypertension (PH) and finally to death by right heart failure.
Lavinia Neubert   +12 more
doaj   +2 more sources

Pulmonary Veno-Occlusive Disease [PDF]

open access: yesCirculation, 1966
A woman, 45 years old at the time of her death, showed the clinical features of primary pulmonary hypertension and the results of cardiac catheterization and pulmonary function tests were consistent with this diagnosis. Histological examination of the lung showed that the pulmonary veins were severely involved by cellular fibrous tissue.
D, Heath, N, Segel, J, Bishop
  +8 more sources

Pulmonary veno-occlusive disease: a clinical review. [PDF]

open access: diamondBreathe (Sheff)
Deshwal H, Sarkar S, Basu A, Jalil BA.
europepmc   +2 more sources

Targeted therapy in pulmonary veno-occlusive disease: time for a rethink? [PDF]

open access: yesBMC Pulmonary Medicine, 2019
Background Pulmonary veno-occlusive disease (PVOD) is a rare condition with poor prognosis, and lung transplantation is recommended as the only curative therapy.
Qin Luo   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy